These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33880030)

  • 21. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.
    Castañeda S; Remuzgo-Martínez S; López-Mejías R; Genre F; Calvo-Alén J; Llorente I; Aurrecoechea E; Ortiz AM; Triguero A; Blanco R; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2019; 37(3):465-473. PubMed ID: 30418124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
    Alam J; Jantan I; Bukhari SNA
    Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF-
    Corrado A; Colia R; Rotondo C; Sanpaolo E; Cantatore FP
    Curr Med Res Opin; 2019 Dec; 35(12):2197-2205. PubMed ID: 31397188
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin resistance and metabolic syndrome - a different image of disorders in rheumatoid arthritis and ankylosing spondylitis].
    Dąbrowski P; Majdan M
    Wiad Lek; 2015; 68(3):235-41. PubMed ID: 26753206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
    Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory markers in patients with rheumatoid arthritis.
    Shrivastava AK; Singh HV; Raizada A; Singh SK; Pandey A; Singh N; Yadav DS; Sharma H
    Allergol Immunopathol (Madr); 2015; 43(1):81-7. PubMed ID: 24656623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of methotrexate and low-dose prednisolone on adiponectine levels and insulin resistance in patients with rheumatoid arthritis naïve to disease-modifying antirheumatic drugs.
    Yaşar Bilge NŞ; Kaşifoğlu N; Kaşifoğlu T; Şahin F; Gönüllü E; Korkmaz C
    Int J Rheum Dis; 2016 Jul; 19(7):665-71. PubMed ID: 26222244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
    Clin Exp Rheumatol; 2006; 24(1):83-6. PubMed ID: 16539824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amylin in the insulin resistance of patients with rheumatoid arthritis.
    Ferraz-Amaro I; López-Mejias R; Tejera-Segura B; de Vera-González AM; Ubilla B; Olmos JM; Hernández JL; González-Gay MA
    Clin Exp Rheumatol; 2018; 36(3):421-427. PubMed ID: 29352842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.
    Tejera-Segura B; López-Mejías R; de Vera-González A; Delgado-González A; González-Gay MA; Ferraz-Amaro I
    Clin Exp Rheumatol; 2019; 37(3):373-379. PubMed ID: 30299246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.
    Ichise Y; Saegusa J; Tanaka-Natsui S; Naka I; Hayashi S; Kuroda R; Morinobu A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.
    Cugno M; Ingegnoli F; Gualtierotti R; Fantini F
    Curr Vasc Pharmacol; 2010 Mar; 8(2):285-92. PubMed ID: 19485909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
    Day AL; Singh JA
    Drugs Aging; 2019 Jun; 36(6):493-510. PubMed ID: 30953327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.